Recurring pleural effusions are a significant cause of patient morbidity. Treatment goals are to relieve distressing symptoms (eg, dyspnea, pain) caused by the effusion, to prevent further extracellular fluid accumulation in the pleural space, and to restore the patient to a functional pulmonary ...
Although significant recent advances have been made in the management of pleural effusions, there the need still remains for further research if we are to reduce the morbidity and mortality caused by pleural effusions. 展开 关键词: fibrinolytics indwelling pleural catheters malignant parapneumonic ...
Intrapleural administration of fibrinolytic agents has been shown to be effective and safe in the treatment of loculated parapneumonic pleural effusions. H... D Bouros,S Schiza,N Tzanakis,... - 《Am J Respir Crit Care Med》 被引量: 414发表: 1999年 Treatment of loculated pleural effusion...
The thoracoscopic surgery and the video-assisted thoracic surgery have made a remarkable progress in the diagnosis and the treatment of the pleural effusions. The advantages of the mini-invasive surgery and its relatively simple technique have allowed the abandon of the traditional thoracotomies ...
If a pleural effusion is left untreated, complications such as a permanent decrease in lung function, sepsis, and lung scarring can occur. Death can also be a result. What are the two types of pleural effusion? The two types of pleural effusions are: ...
C Tomasini,AC Butera,M Pippione - 《American Journal of Dermatopathology》 被引量: 1发表: 2008年 METHOD AND APPARATUS FOR TREATING FLUID BUILD-UP IN A BODY CAVITY, INCLUDING METHOD AND APPARATUS FOR TREATING ASCITES AND PLEURAL EFFUSIONS A method for treating pleural effusion in a patient, ...
Vascular endothelial growth factor-A (VEGF-A) has been implicated as a critical cytokine in the formation of malignant pleural effusions. Elevated levels of VEGF produced by tumor cells, mesothelial cells, and infiltrating immune cells result in increased vascular permeability, cancer cell ...
Intrapleural urokinase in the treatment of complicated parapneumonic pleural effusions and empyema Intrapleural urokinase has not been evaluated systemically in terms of efficacy, safety, and cost of treatment in a large series of patients with complicat... D Bouros,S Schiza,N Tzanakis,... -...
The use of indwelling pleural catheters for the treatment of malignant pleural effusions Introduction The presence of a malignant pleural effusion (MPE) is a marker of advanced disease and associated with a poor prognosis. Patients are in a pal... T Syer,S Walker,N Maskell - 《Expert Review...
Recurrent pleural effusions are frequently encountered in clinical practice. Whether malignant or nonmalignant, they often pose a challenge to the practicing clinician. When they recur, despite optimum medical therapy of the underlying condition and repeated thoracenteses, more invasive definitive approaches...